- $2.36bn
- $2.12bn
- $74.21m
Brief: Alamar Biosciences Names Former Grail CEO Bob Ragusa To Board Of Directors And Expands Leadership Team
US RESEARCH ROUNDUP-Autozone, General Mills, JPMorgan
Alamar Biosciences Inc reports results for the quarter ended June 30 - Earnings Summary
Alamar Biosciences Inc expected to post a loss of 33 cents a share - Earnings Preview
Kardigan surges in Nasdaq debut after upsized $400 million IPO (updated)
U.S. RESEARCH ROUNDUP-Accuray, Aevex, Zoetis
Biotech firm Odyssey valued at $899.9 million as shares rises in Nasdaq debut (updated)
Biotech firm Odyssey valued at $899.9 million as shares rises in Nasdaq debut
Biotech firm Odyssey raises $279 million in upsized US IPO (updated)
Biotech firm Odyssey targets $810 million valuation in US IPO (updated)